Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Axera Enterprises Private Limited, is an unlisted private company incorporated on 09 March, 2018. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 10,000.00 and the total paid-up capital is INR 10,000.00 .
The current status of Axera Enterprises Private Limited is - Active.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Smriti Rajesh Agrawal | 00075064 | 7 years |
| Director | Manisha Yogesh Agrawal | 00075762 | 7 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SWADESH CAPITAL PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| RITEAID FINANCE PRIVATE LIMITED |
Active
|
9.0 L | 2 | Maharashtra |
| AXERA PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| ALMIRON PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| GLEAMIO TRADING PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| GENCREST PRIVATE LIMITED |
Converted to LLP
|
10.0 L | 1 | Maharashtra |
| ILLUMA OPTHALMACEUTICALS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| SUNDER AJANTA INFRASTRUCTURES LIMITED |
Converted to LLP
|
1.2 Cr | 2 | Maharashtra |
| VETRIUM HEALTH PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| NUVENTA PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| ALMIRON PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| SUNCITY COMMODITIES PRIVATE LIMITED |
Active
|
32.0 L | 1 | West Bengal |
| AVECIA PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| NUVENTA PHARMA LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| CDC PHARMA LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| AVECIA PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| AUREUS PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| ZILLION LABS LLP |
Active
|
1.0 L | 2 | Maharashtra |
| AXERA PHARMA LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| RENAMAX LABS LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| ANSCA DERMACEUTICALS LLP |
Under Process Of Strike Off
|
1.0 L | 2 | Maharashtra |
| ANVAXX LABORATORIES LLP |
Active
|
1.2 L | 2 | Maharashtra |
| ILLUMA OPTHALMACEUTICALS LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| VETRIUM HEALTH LLP |
Strike Off
|
1.0 L | 2 | Maharashtra |
| ALMIRON PHARMA LLP |
Active
|
1.0 L | 2 | Maharashtra |
| RITEAID ENTERPRISES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| GANGA BUILDERS PRIVATE LIMITED |
Active
|
14.3 L | 1 | Maharashtra |
| ANVAXX LABORATORIES PRIVATE LIMITED |
Converted to LLP
|
1.2 L | 1 | Maharashtra |
| ARCADE EXIM PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| INSPIRA LIVING CONCEPTS PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| ZILLION LABS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| INTIMACY EXIM PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ANSCA DERMACEUTICALS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| RENAMAX LABS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 1 | Maharashtra |
| INSPIRA ENERGY LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| INSPIRA SOLAR PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| INSPIRA SOLAR ENERGY PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| NUVENTA ENTERPRISES LLP |
Under process of striking off
|
1.0 L | 1 | Maharashtra |
The incorporation date of AXERA ENTERPRISES PRIVATE LIMITED is 09 March, 2018
The authorized share capital of AXERA ENTERPRISES PRIVATE LIMITED is INR ₹ 10,000.0 .
The paid-up capital of AXERA ENTERPRISES PRIVATE LIMITED is INR ₹ 10,000.0 .
The registered address of AXERA ENTERPRISES PRIVATE LIMITED is Ajanta House 98, Govt Industrial Area Charkop, Kandivali (West) MUMBAI Mumbai City Maharashtra - 400067
The CIN number of AXERA ENTERPRISES PRIVATE LIMITED is U74999MH2018PTC306226.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
